Updated on 17 May 2012
Presently, focus is on pilot production of regular cartridge for clinical trials. AWAK Technologies will conduct phase I human study upon successful pre-clinical trial in Singapore, the US and Germany. The first-in-human trial will be done with Singapore General Hospital and the first-in-pediatrics with the University Children Hospital Tubingen, Germany.
In September 2011, AWAK Technologies was awarded a contract by the US Department of Veteran Affair to conduct a study of AWAK system based on three regular cartridges on a daily basis. The study shall validate the safety and efficacy of AWAK with an animal trial, preceded by a series of in vitro and ex vivo studies. The study will be done in San Diego and Minneapolis in the US.